Literature DB >> 6046683

Rocky Mountain spotted fever acquired in a laboratory.

J E Johnson, P J Kadull.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6046683     DOI: 10.1056/NEJM196710192771603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever.

Authors:  S Vishwanath; G A McDonald; N G Watkins
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.

Authors:  R H Kenyon; C E Pedersen
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

Review 3.  [Rickettsioses of the spotted fever-group].

Authors:  S Bassetti
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

4.  Use of a sensitive microplate enzyme-linked immunosorbent assay in a retrospective serological analysis of a laboratory population at risk to infection with typhus group rickettsiae.

Authors:  S Halle; G A Dasch
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

5.  Needlestick-Associated Rocky Mountain Spotted Fever, Brazil.

Authors:  Stefan Vilges de Oliveira; Álvaro A Faccini-Martínez; Talita Emile Ribeiro Adelino; Ana Íris de Lima Duré; Amalia R M Barbieri; Marcelo B Labruna
Journal:  Emerg Infect Dis       Date:  2020       Impact factor: 6.883

6.  Serological Evidence of Exposure to Spotted Fever Group and Typhus Group Rickettsiae in Australian Wildlife Rehabilitators.

Authors:  Karen O Mathews; David Phalen; Jacqueline M Norris; John Stenos; Jenny-Ann Toribio; Nicholas Wood; Stephen Graves; Paul A Sheehy; Chelsea Nguyen; Katrina L Bosward
Journal:  Pathogens       Date:  2021-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.